Interventions for valvular disease and heart failure

RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation

EuroIntervention 2016;11:e1658-e1661 published online e-edition April 2016. DOI: 10.4244/EIJV11I14A317

Gabriella Visconti1, MD; Amelia Focaccio1, MD; Michael Donahue1, MD; Bruno Golia1, MD; Antonio Marzano1, MD; Elvira Donnarumma2, PhD; Bruno Ricciardelli1, MD; Lucio Selvetella3, MD; Luigi Marino4, MD; Carlo Briguori1*, MD, PhD

1. Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy; 2. IRCCS SDN, Naples, Italy; 3. Department of Vascular Surgery, Clinica Mediterranea, Naples, Italy; 4. Department of Cardiac Surgery, Clinica Me

Aims: We aimed to assess whether the RenalGuard™ System is effective in preventing acute kidney injury (AKI) following transcatheter aortic valve implantation (TAVI).

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic valve stenosiscomplicationkidneyprevention

Interventions for valvular diseaseTAVITools, devices and techniques

Share on Facebook Share on Twitter Share on Linkedin